0000899243-18-019862.txt : 20180713
0000899243-18-019862.hdr.sgml : 20180713
20180713200030
ACCESSION NUMBER: 0000899243-18-019862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180712
FILED AS OF DATE: 20180713
DATE AS OF CHANGE: 20180713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelbon Marcia S.
CENTRAL INDEX KEY: 0001472163
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34475
FILM NUMBER: 18953417
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OMEROS CORP
CENTRAL INDEX KEY: 0001285819
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911663741
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-676-5000
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVENUE WEST
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-12
0
0001285819
OMEROS CORP
OMER
0001472163
Kelbon Marcia S.
201 ELLIOTT AVENUE WEST
SEATTLE
WA
98119
0
1
0
0
VP Patent and General Counsel
Common Stock
2018-07-12
4
M
0
4277
4.10
A
188922
D
Common Stock
2018-07-12
4
S
0
4277
21.4838
D
184645
D
Stock Option (Right to Buy)
4.10
2018-07-12
4
M
0
4277
0.00
D
2022-01-07
Common Stock
4277
83252
D
Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, and amended on May 17, 2018. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This transaction was executed in multiple trades at prices ranging from $21.46 to $21.49; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011.
/s/ Marcia S. Kelbon
2018-07-13